MicroRNA mediated network and DNA methylation in colorectal cancer

Protein and Peptide Letters

Volumn 20, Issue 3, 2013, Pages 352-363

  Li, Bi Qing ^a,b   Yu, Hui ^a,b   Wang, Zhen ^a,b   Ding, Guo Hui ^a,b   Liu, Lei ^a,b  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Colorectal cancer; Dna methylation; Microrna; Regulatory network

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 106B; MICRORNA 93; NF KAPPA B2 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F2; TRANSCRIPTION FACTOR E2F5; UNCLASSIFIED DRUG;

APPL1 GENE; ARTICLE; BREAST CANCER; COLORECTAL CANCER; DNA METHYLATION; EPIGENETICS; ESOPHAGUS CANCER; GENE; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC ANALYSIS; GENETIC ASSOCIATION; MOLECULAR PATHOLOGY; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE GENE; REGULATORY MECHANISM; SYSTEMS BIOLOGY; TRANSCRIPTION FACTOR E2F1 GENE;

EID: 84877038390     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929866511320030014     Document Type: Article

References (80)

1. Hartwell, L.H.; Hopfield, J.J.; Leibler, S.; Murray, A. W. From molecular to modular cell biology. Nature, 1999, 402(6761 Suppl), C47-52.
2. Hood, L.; Heath, J.R.; Phelps, M.E.; Lin, B. Systems biology and new technologies enable predictive and preventative medicine. Science, 2004, 306(5696), 640-3.
3. Hornberg, J.J.; Bruggeman, F.J.; Westerhoff, H.V.; Lankelma, J. Cancer: a Systems Biology disease. Biosystems, 2006, 83(2-3), 81-90.
4. Vogelstein, B.; Kinzler, K.W. Cancer genes and the pathways they control. Nat. Med., 2004, 10(8), 789-99.
5. Esquela-Kerscher, A.; Slack, F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer, 2006, 6(4), 259-69.
6. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M. J. Cancer statistics, 2009. CA Cancer J. Clin., 2009, 59(4), 225-49.
7. Grady, W.M.; Carethers, J.M. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology, 2008, 135(4), 1079-99.
8. Egger, G.; Liang, G.; Aparicio, A.; Jones, P.A. Epigenetics in human disease and prospects for epigenetic therapy. Nature, 2004, 429(6990), 457-63.
9. Fabian, M.R.; Sonenberg, N.; Filipowicz, W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem., 2010, 79, 351-79.
10. Nagel, R.; le Sage, C.; Diosdado, B.; van der Waal, M.; Oude Vrielink, J.A.; Bolijn, A.; Meijer, G.A.; Agami, R. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res., 2008, 68(14), 5795-802.
11. Valeri, N.; Gasparini, P.; Fabbri, M.; Braconi, C.; Veronese, A.; Lovat, F.; Adair, B.; Vannini, I.; Fanini, F.; Bottoni, A.; Costinean, S.; Sandhu, S.K.; Nuovo, G.J.; Alder, H.; Gafa, R.; Calore, F.; Ferracin, M.; Lanza, G.; Volinia, S.; Negrini, M.; McIlhatton, M.A.; Amadori, D.; Fishel, R.; Croce, C.M. Modulation of mismatch repair and genomic stability by miR-155. Proc. Natl. Acad. Sci. USA, 2010, 107(15), 6982-7.
12. Kane, M.F.; Loda, M.; Gaida, G.M.; Lipman, J.; Mishra, R.; Goldman, H.; Jessup, J.M.; Kolodner, R., Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res., 1997, 57(5), 808-11.
13. Cunningham, J.M.; Christensen, E.R.; Tester, D.J.; Kim, C.Y.; Roche, P.C.; Burgart, L.J.; Thibodeau, S.N. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res., 1998, 58(15), 3455-60.
14. Herman, J.G.; Umar, A.; Polyak, K.; Graff, J.R.; Ahuja, N.; Issa, J.P.; Markowitz, S.; Willson, J.K.; Hamilton, S.R.; Kinzler, K.W.; Kane, M.F.; Kolodner, R.D.; Vogelstein, B.; Kunkel, T.A.; Baylin, S.B. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA, 1998, 95(12), 6870-5.
15. Esteller, M.; Sparks, A.; Toyota, M.; Sanchez-Cespedes, M.; Capella, G.; Peinado, M.A.; Gonzalez, S.; Tarafa, G.; Sidransky, D.; Meltzer, S.J.; Baylin, S.B.; Herman, J.G. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res., 2000, 60(16), 4366-71.
16. Lujambio, A.; Calin, G.A.; Villanueva, A.; Ropero, S.; Sanchez- Cespedes, M.; Blanco, D.; Montuenga, L.M.; Rossi, S.; Nicoloso, M.S.; Faller, W.J.; Gallagher, W.M.; Eccles, S.A.; Croce, C.M.; Esteller, M. A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl. Acad. Sci. USA, 2008, 105(36), 13556-61.
17. Ng, E.K.; Tsang, W.P.; Ng, S.S.; Jin, H. C.; Yu, J.; Li, J.J.; Rocken, C.; Ebert, M.P.; Kwok, T.T.; Sung, J.J. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br. J. Cancer 2009, 101(4), 699-706.
18. Roberts, R.J. PubMed Central: The GenBank of the published literature. Proc. Natl. Acad. Sci. USA, 2001, 98 (2), 381-2.
19. Volinia, S.; Calin, G.A.; Liu, C.G.; Ambs, S.; Cimmino, A.; Petrocca, F.; Visone, R.; Iorio, M.; Roldo, C.; Ferracin, M.; Prueitt, R.L.; Yanaihara, N.; Lanza, G.; Scarpa, A.; Vecchione, A.; Negrini, M.; Harris, C.C.; Croce, C.M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA, 2006, 103(7), 2257-61.
20. Yang, H.; Gu, J.; Wang, K.K.; Zhang, W.; Xing, J.; Chen, Z.; Ajani, J.A.; Wu, X. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clin. Cancer Res., 2009, 15(18), 5744-52.
21. Guo, Y.; Chen, Z.; Zhang, L.; Zhou, F.; Shi, S.; Feng, X.; Li, B.; Meng, X.; Ma, X.; Luo, M.; Shao, K.; Li, N.; Qiu, B.; Mitchelson, K.; Cheng, J.; He, J., Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res., 2008, 68 (1), 26-33.
22. Griffiths-Jones, S.; Saini, H. K.; van Dongen, S.; Enright, A. J., miRBase: tools for microRNA genomics. Nucleic Acids Res., 2008, 36 (Database issue), D154-8.
23. Kanehisa, M., The KEGG database. Novartis Found. Symp., 2002, 247, 91-101; discussion 101-3, 119-28, 244-52.
24. Selbach, M.; Schwanhausser, B.; Thierfelder, N.; Fang, Z.; Khanin, R.; Rajewsky, N., Widespread changes in protein synthesis induced by microRNAs. Nature., 2008, 455 (7209), 58-63.
25. Baek, D.; Villen, J.; Shin, C.; Camargo, F. D.; Gygi, S. P.; Bartel, D. P., The impact of microRNAs on protein output. Nature. 2008, 455 (7209), 64-71.
26. Lewis, B. P.; Burge, C. B.; Bartel, D. P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 2005, 120 (1), 15-20.
27. Grimson, A.; Farh, K. K.; Johnston, W. K.; Garrett-Engele, P.; Lim, L. P.; Bartel, D. P., MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell, 2007, 27 (1), 91-105.
28. Friedman, R. C.; Farh, K. K.; Burge, C. B.; Bartel, D. P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Res., 2009, 19 (1), 92-105.
29. Haider, S.; Ballester, B.; Smedley, D.; Zhang, J.; Rice, P.; Kasprzyk, A., BioMart Central Portal-unified access to biological data. Nucleic Acids Res., 2009, 37 (Web Server issue), W23-7.
30. McCabe, M. T.; Brandes, J. C.; Vertino, P. M., Cancer DNA methylation: molecular mechanisms and clinical implications. Clin Cancer Res., 2009, 15 (12), 3927-37.
31. Shalgi, R.; Lieber, D.; Oren, M.; Pilpel, Y., Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput. Biol., 2007, 3 (7), e131.
32. Rhead, B.; Karolchik, D.; Kuhn, R. M.; Hinrichs, A. S.; Zweig, A. S.; Fujita, P. A.; Diekhans, M.; Smith, K. E.; Rosenbloom, K. R.; Raney, B. J.; Pohl, A.; Pheasant, M.; Meyer, L. R.; Learned, K.; Hsu, F.; Hillman-Jackson, J.; Harte, R. A.; Giardine, B.; Dreszer, T. R.; Clawson, H.; Barber, G. P.; Haussler, D.; Kent, W. J., The UCSC Genome Browser database: update 2010. Nucleic Acids Res., 2010, 38 (Database issue), D613-9.
33. Shannon, P.; Markiel, A.; Ozier, O.; Baliga, N. S.; Wang, J. T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res., 2003, 13 (11), 2498-504.
34. Shu-Hwa Chen, C.-H. C., Hsin-Hung Wu, Chin-Wen Ho, Ming-Tat Ko, Chung-Yen Lin, cyto-Hubba: a Cytoscape Plug-in for Hub Object Analysis in Network Biology. Genome Informatics Workshop poster 2009.
35. Team, R. D. C., R: A Language and Environment for Statistical Computing. 2008.
36. Irizarry, R. A.; Ladd-Acosta, C.; Wen, B.; Wu, Z.; Montano, C.; Onyango, P.; Cui, H.; Gabo, K.; Rongione, M.; Webster, M.; Ji, H.; Potash, J. B.; Sabunciyan, S.; Feinberg, A. P., The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet., 2009, 41 (2), 178-86.
37. Han, J. D.; Bertin, N.; Hao, T.; Goldberg, D. S.; Berriz, G. F.; Zhang, L. V.; Dupuy, D.; Walhout, A. J.; Cusick, M. E.; Roth, F. P.; Vidal, M., Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature, 2004, 430 (6995), 88-93.
38. Jordan, I. K.; Marino-Ramirez, L.; Wolf, Y. I.; Koonin, E. V., Conservation and coevolution in the scale-free human gene coexpression network. Mol. Biol. Evol., 2004, 21 (11), 2058-70.
39. Steck, P. A.; Pershouse, M. A.; Jasser, S. A.; Yung, W. K.; Lin, H.; Ligon, A. H.; Langford, L. A.; Baumgard, M. L.; Hattier, T.; Davis, T.; Frye, C.; Hu, R.; Swedlund, B.; Teng, D. H.; Tavtigian, S. V., Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 1997, 15 (4), 356-62.
40. Li, J.; Yen, C.; Liaw, D.; Podsypanina, K.; Bose, S.; Wang, S. I.; Puc, J.; Miliaresis, C.; Rodgers, L.; McCombie, R.; Bigner, S. H.; Giovanella, B. C.; Ittmann, M.; Tycko, B.; Hibshoosh, H.; Wigler, M. H.; Parsons, R., PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 1997, 275 (5308), 1943-7.
41. Li, J.; Simpson, L.; Takahashi, M.; Miliaresis, C.; Myers, M. P.; Tonks, N.; Parsons, R., The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. Cancer Res., 1998, 58 (24), 5667-72.
42. Stambolic, V.; Suzuki, A.; de la Pompa, J. L.; Brothers, G. M.; Mirtsos, C.; Sasaki, T.; Ruland, J.; Penninger, J. M.; Siderovski, D. P.; Mak, T. W., Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell, 1998, 95 (1), 29-39.
43. Wu, X.; Senechal, K.; Neshat, M. S.; Whang, Y. E.; Sawyers, C. L., The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. U S A, 1998, 95 (26), 15587-91.
44. Wang, S. I.; Puc, J.; Li, J.; Bruce, J. N.; Cairns, P.; Sidransky, D.; Parsons, R., Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res., 1997, 57 (19), 4183-6.
45. Whiteman, D. C.; Zhou, X. P.; Cummings, M. C.; Pavey, S.; Hayward, N. K.; Eng, C., Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma. Int. J. Cancer, 2002, 99 (1), 63-7.
46. Cairns, P.; Okami, K.; Halachmi, S.; Halachmi, N.; Esteller, M.; Herman, J. G.; Jen, J.; Isaacs, W. B.; Bova, G. S.; Sidransky, D., Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res., 1997, 57 (22), 4997-5000.
47. Mutter, G. L.; Lin, M. C.; Fitzgerald, J. T.; Kum, J. B.; Baak, J. P.; Lees, J. A.; Weng, L. P.; Eng, C., Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J. Natl. Cancer Inst., 2000, 92 (11), 924-30.
48. Nassif, N. T.; Lobo, G. P.; Wu, X.; Henderson, C. J.; Morrison, C. D.; Eng, C.; Jalaludin, B.; Segelov, E., PTEN mutations are common in sporadic microsatellite stable colorectal cancer. Oncogene, 2004, 23 (2), 617-28.
49. Goel, A.; Arnold, C. N.; Niedzwiecki, D.; Carethers, J. M.; Dowell, J. M.; Wasserman, L.; Compton, C.; Mayer, R. J.; Bertagnolli, M. M.; Boland, C. R., Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res., 2004, 64 (9), 3014-21.
50. Guanti, G.; Resta, N.; Simone, C.; Cariola, F.; Demma, I.; Fiorente, P.; Gentile, M., Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis. Hum. Mol. Genet., 2000, 9 (2), 283-7.
51. Dicuonzo, G.; Angeletti, S.; Garcia-Foncillas, J.; Brugarolas, A.; Okrouzhnov, Y.; Santini, D.; Tonini, G.; Lorino, G.; De Cesaris, M.; Baldi, A., Colorectal carcinomas and PTEN/MMAC1 gene mutations. Clin. Cancer Res., 2001, 7 (12), 4049-53.
52. Zhou, X. P.; Loukola, A.; Salovaara, R.; Nystrom-Lahti, M.; Peltomaki, P.; de la Chapelle, A.; Aaltonen, L. A.; Eng, C., PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers. Am. J. Pathol., 2002, 161 (2), 439-47.
53. Agarwal, A.; Das, K.; Lerner, N.; Sathe, S.; Cicek, M.; Casey, G.; Sizemore, N., The AKT/I kappa B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-kappa B and beta-catenin. Oncogene, 2005, 24 (6), 1021-31.
54. Sawai, H.; Yasuda, A.; Ochi, N.; Ma, J.; Matsuo, Y.; Wakasugi, T.; Takahashi, H.; Funahashi, H.; Sato, M.; Takeyama, H., Loss of PTEN expression is associated with colorectal cancer liver metastasis and poor patient survival. BMC Gastroenterol, 2008, 8, 56.
55. Huang, T.; Shi, X. H.; Wang, P.; He, Z.; Feng, K. Y.; Hu, L.; Kong, X.; Li, Y. X.; Cai, Y. D.; Chou, K. C., Analysis and prediction of the metabolic stability of proteins based on their sequential features, subcellular locations and interaction networks. PLoS ONE, 2010, 5 (6), e10972.
56. Dimova, D. K.; Dyson, N. J., The E2F transcriptional network: old acquaintances with new faces. Oncogene 2005, 24 (17), 2810-26.
57. Polager, S.; Ginsberg, D., E2F - at the crossroads of life and death. Trends Cell Biol., 2008, 18 (11), 528-35.
58. Stanelle, J.; Putzer, B. M., E2F1-induced apoptosis: turning killers into therapeutics. Trends Mol. Med., 2006, 12 (4), 177-85.
59. Elliott, M. J.; Dong, Y. B.; Yang, H.; McMasters, K. M., E2F-1 upregulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells. Clin. Cancer Res., 2001, 7 (11), 3590-7.
60. Bramis, J.; Zacharatos, P.; Papaconstantinou, I.; Kotsinas, A.; Sigala, F.; Korkolis, D. P.; Nikiteas, N.; Pazaiti, A.; Kittas, C.; Bastounis, E.; Gorgoulis, V. G., E2F-1 transcription factor immunoexpression is inversely associated with tumor growth in colon adenocarcinomas. Anticancer Res., 2004, 24 (5A), 3041-7.
61. Dong, Y. B.; Yang, H. L.; McMasters, K. M., E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin. Cancer Gene. Ther., 2003, 10 (3), 168-78.
62. Liu, J.; Yao, F.; Wu, R.; Morgan, M.; Thorburn, A.; Finley, R. L., Jr.; Chen, Y. Q., Mediation of the DCC apoptotic signal by DIP13 alpha. J. Biol. Chem., 2002, 277 (29), 26281-5.
63. Miaczynska, M.; Christoforidis, S.; Giner, A.; Shevchenko, A.; Uttenweiler-Joseph, S.; Habermann, B.; Wilm, M.; Parton, R. G.; Zerial, M., APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell, 2004, 116 (3), 445-56.
64. Varsano, T.; Dong, M. Q.; Niesman, I.; Gacula, H.; Lou, X.; Ma, T.; Testa, J. R.; Yates, J. R., 3rd; Farquhar, M. G., GIPC is recruited by APPL to peripheral TrkA endosomes and regulates TrkA trafficking and signaling. Mol. Cell Biol., 2006, 26 (23), 8942-52.
65. Schenck, A.; Goto-Silva, L.; Collinet, C.; Rhinn, M.; Giner, A.; Habermann, B.; Brand, M.; Zerial, M., The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development. Cell, 2008, 133 (3), 486-97.
66. Mao, X.; Kikani, C. K.; Riojas, R. A.; Langlais, P.; Wang, L.; Ramos, F. J.; Fang, Q.; Christ-Roberts, C. Y.; Hong, J. Y.; Kim, R. Y.; Liu, F.; Dong, L. Q., APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat. Cell Biol., 2006, 8 (5), 516-23.
67. Betel, D.; Wilson, M.; Gabow, A.; Marks, D. S.; Sander, C., The microRNA.org resource: targets and expression. Nucleic Acids Res., 2008, 36 (Database issue), D149-53.
68. Chandrasekar, B.; Boylston, W. H.; Venkatachalam, K.; Webster, N. J.; Prabhu, S. D.; Valente, A. J., Adiponectin blocks interleukin- 18-mediated endothelial cell death via APPL1-dependent AMPactivated protein kinase (AMPK) activation and IKK/NFkappaB/ PTEN suppression. J. Biol. Chem., 2008, 283 (36), 24889-98.
69. Brosh, R.; Shalgi, R.; Liran, A.; Landan, G.; Korotayev, K.; Nguyen, G. H.; Enerly, E.; Johnsen, H.; Buganim, Y.; Solomon, H.; Goldstein, I.; Madar, S.; Goldfinger, N.; Borresen-Dale, A. L.; Ginsberg, D.; Harris, C. C.; Pilpel, Y.; Oren, M.; Rotter, V., p53- Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation. Mol. Syst. Biol., 2008, 4, 229.
70. Aguda, B. D.; Kim, Y.; Piper-Hunter, M. G.; Friedman, A.; Marsh, C. B., MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc. Natl. Acad Sci. U S A., 2008, 105 (50), 19678-83.
71. Coller, H. A.; Forman, J. J.; Legesse-Miller, A., "Myc'ed messages": myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron. PLoS Genet., 2007, 3 (8), e146.
72. Carraro, G.; El-Hashash, A.; Guidolin, D.; Tiozzo, C.; Turcatel, G.; Young, B. M.; De Langhe, S. P.; Bellusci, S.; Shi, W.; Parnigotto, P. P.; Warburton, D., miR-17 family of microRNAs controls FGF10-mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of ECadherin distribution. Dev. Biol., 2009, 333 (2), 238-50.
73. Foshay, K. M.; Gallicano, G. I., miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation. Dev. Biol., 2009, 326 (2), 431-43.
74. Snyder, M.; Huang, X. Y.; Zhang, J. J., Identification of novel direct Stat3 target genes for control of growth and differentiation. J. Biol., Chem., 2008, 283 (7), 3791-8.
75. Xiao, C.; Srinivasan, L.; Calado, D. P.; Patterson, H. C.; Zhang, B.; Wang, J.; Henderson, J. M.; Kutok, J. L.; Rajewsky, K., Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol., 2008, 9 (4), 405-14.
76. Olive, V.; Bennett, M. J.; Walker, J. C.; Ma, C.; Jiang, I.; Cordon- Cardo, C.; Li, Q. J.; Lowe, S. W.; Hannon, G. J.; He, L., miR-19 is a key oncogenic component of mir-17-92. Genes. Dev., 2009, 23 (24), 2839-49.
77. Mu, P.; Han, Y. C.; Betel, D.; Yao, E.; Squatrito, M.; Ogrodowski, P.; de Stanchina, E.; D'Andrea, A.; Sander, C.; Ventura, A., Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes. Dev., 2009, 23 (24), 2806-11.
78. Vasudevan, K. M.; Gurumurthy, S.; Rangnekar, V. M., Suppression of PTEN expression by NF-kappa B prevents apoptosis. Mol. Cell Biol., 2004, 24 (3), 1007-21.
79. Zhou, R.; Hu, G.; Gong, A. Y.; Chen, X. M., Binding of NFkappaB p65 subunit to the promoter elements is involved in LPSinduced transactivation of miRNA genes in human biliary epithelial cells. Nucleic. Acids Res., 2010, 38 (10), 3222-32.
80. Sinha, A. U.; Kaimal, V.; Chen, J.; Jegga, A. G., Dissecting microregulation of a master regulatory network. BMC Genomics, 2008, 9, 88.